Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20211853Phase 3Completed
A Phase 3 trial of esketamine, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20211853.